IN2012DN01314A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01314A
IN2012DN01314A IN1314DEN2012A IN2012DN01314A IN 2012DN01314 A IN2012DN01314 A IN 2012DN01314A IN 1314DEN2012 A IN1314DEN2012 A IN 1314DEN2012A IN 2012DN01314 A IN2012DN01314 A IN 2012DN01314A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Christopher Michael Kevin Springate
Original Assignee
Arc Medical Devices Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arc Medical Devices Inc filed Critical Arc Medical Devices Inc
Publication of IN2012DN01314A publication Critical patent/IN2012DN01314A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1314DEN2012 2009-07-27 2012-02-13 IN2012DN01314A (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22892909P 2009-07-27 2009-07-27
PCT/CA2010/001175 WO2011011881A1 (en) 2009-07-27 2010-07-27 Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders

Publications (1)

Publication Number Publication Date
IN2012DN01314A true IN2012DN01314A (ar) 2015-06-05

Family

ID=43497856

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1314DEN2012 IN2012DN01314A (ar) 2009-07-27 2012-02-13

Country Status (20)

Country Link
US (6) US8466125B2 (ar)
EP (2) EP2459200A4 (ar)
JP (5) JP2013500274A (ar)
KR (1) KR20120083297A (ar)
CN (2) CN102665733B (ar)
AR (1) AR078082A1 (ar)
AU (4) AU2010278640A1 (ar)
BR (1) BR112012008072A2 (ar)
CA (2) CA3046665C (ar)
CL (1) CL2012000215A1 (ar)
EA (1) EA201270186A1 (ar)
IN (1) IN2012DN01314A (ar)
JO (1) JO3676B1 (ar)
MX (1) MX2012001212A (ar)
MY (1) MY168759A (ar)
PH (1) PH12012500177A1 (ar)
SG (3) SG10201808960VA (ar)
TW (2) TWI491396B (ar)
WO (1) WO2011011881A1 (ar)
ZA (1) ZA201200999B (ar)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2989941A1 (en) * 2004-09-23 2006-03-30 Arc Pharmaceuticals, Inc. Pharmaceutical compostions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
JO3676B1 (ar) * 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
CA2790682C (en) 2010-03-03 2020-11-24 Neocutis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
FR2984126B1 (fr) * 2011-12-20 2014-08-22 Oreal Polysaccharides sulfates agent antipelliculaire
JP2018510905A (ja) * 2015-02-16 2018-04-19 エグザンシャル 皮膚障害の予防又は治療のための組成物
CN105663154B (zh) * 2016-01-18 2020-06-30 首都医科大学 褐藻多糖硫酸酯在制备预防和/或治疗下肢外周动脉血管病的产品中的应用
US20180056087A1 (en) * 2016-08-26 2018-03-01 Adolfo Ribeiro Wearable Micro-LED Healing Bandage
CN106943619A (zh) * 2017-03-17 2017-07-14 清华大学 一种液体伤口敷料及其制备方法
US12186334B2 (en) 2018-07-27 2025-01-07 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
US11446326B2 (en) * 2018-07-27 2022-09-20 ARC Medical Devices Highly sulfated fucans for the treatment of fibrous adhesions
MX2021000866A (es) 2019-03-05 2021-06-15 Arc Medical Devices Inc Sistemas y metodos para la filtracion de flujo tangencial de composiciones viscosas.
AU2021210489B2 (en) * 2020-01-23 2025-03-20 Shanghai Synvida Biotechnology Co. Ltd. Related target for treating fibrotic diseases and applications thereof
CN115260328A (zh) * 2022-08-14 2022-11-01 湘潭大学 一种改性岩藻多糖化合物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
IT1288713B1 (it) * 1996-12-18 1998-09-23 Crinos Industria Farmaco Fucani a basso peso molecolare aventi attivita' anticoagulante antitrombinica e antitrombotica
FR2772618B1 (fr) * 1997-12-18 2000-02-18 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
JP4202645B2 (ja) * 1999-08-20 2008-12-24 タカラバイオ株式会社 治療剤
US6812220B2 (en) 2001-08-29 2004-11-02 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
NO320671B1 (no) * 2001-11-30 2006-01-16 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning i fisk.
BRPI0418384A (pt) * 2003-05-30 2007-06-26 Arc Pharmaceuticals Inc composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
CN1829501A (zh) * 2003-05-30 2006-09-06 Arc药品有限公司 涉及使用多种药物抑制纤维粘连的药用组合物和方法
CA2989941A1 (en) * 2004-09-23 2006-03-30 Arc Pharmaceuticals, Inc. Pharmaceutical compostions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
WO2007028256A2 (en) * 2005-09-09 2007-03-15 Les Biotechnologies Oceanova Inc. Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
CN1935154A (zh) * 2006-09-04 2007-03-28 北京世纪博康医药科技有限公司 褐藻多糖硫酸酯在制备治疗心脑血管疾病的药物中的用途
JP5679663B2 (ja) * 2007-02-23 2015-03-04 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated 海藻抽出物からのフコイダン精製のためのプロセスの方法
GB0707096D0 (en) * 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
JO3676B1 (ar) * 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها

Also Published As

Publication number Publication date
PH12012500177A1 (en) 2016-06-22
AU2018203461A1 (en) 2018-06-07
EP3300737A1 (en) 2018-04-04
JP2017206542A (ja) 2017-11-24
KR20120083297A (ko) 2012-07-25
AU2019268096A1 (en) 2019-12-12
TWI491396B (zh) 2015-07-11
WO2011011881A1 (en) 2011-02-03
JP2021020907A (ja) 2021-02-18
CN102665733B (zh) 2016-08-10
JP2016128491A (ja) 2016-07-14
AU2016219615A1 (en) 2016-09-15
US20200115472A1 (en) 2020-04-16
US20140274942A1 (en) 2014-09-18
JP2013500274A (ja) 2013-01-07
CN106176798A (zh) 2016-12-07
CA3046665C (en) 2021-03-23
TW201532607A (zh) 2015-09-01
US20180051097A1 (en) 2018-02-22
MX2012001212A (es) 2012-07-17
TW201105342A (en) 2011-02-16
MY168759A (en) 2018-12-04
SG10201808960VA (en) 2018-11-29
US20180230240A1 (en) 2018-08-16
CA3046665A1 (en) 2011-02-03
CN102665733A (zh) 2012-09-12
CL2012000215A1 (es) 2012-07-13
US20140128340A1 (en) 2014-05-08
EP2459200A4 (en) 2013-02-27
AU2010278640A1 (en) 2012-03-15
EP2459200A1 (en) 2012-06-06
CA2769147A1 (en) 2011-02-03
JO3676B1 (ar) 2020-08-27
SG177741A1 (en) 2012-02-28
JP2019142896A (ja) 2019-08-29
AR078082A1 (es) 2011-10-12
EA201270186A1 (ru) 2012-09-28
BR112012008072A2 (pt) 2016-03-01
SG10201401436VA (en) 2014-10-30
US8466125B2 (en) 2013-06-18
ZA201200999B (en) 2013-05-29
US20110021457A1 (en) 2011-01-27
TWI569801B (zh) 2017-02-11

Similar Documents

Publication Publication Date Title
BRPI0925311A2 (ar)
BR112012008195A2 (ar)
BRPI0924307A2 (ar)
BR112012008267A2 (ar)
BR112012012396A2 (ar)
BR122021004633A2 (ar)
BR112012012487A2 (ar)
BR122017024704A2 (ar)
BRPI0924534A2 (ar)
BR112012012080A2 (ar)
BR112012009797A2 (ar)
BR112012009446A2 (ar)
BR112012009703A2 (ar)
BR112012010357A2 (ar)
BR112012007656A2 (ar)
BRPI1004942A2 (ar)
BR122019005883A2 (ar)
BR112012014856A2 (ar)
BR112012007654A2 (ar)
BR112012007672A2 (ar)
BR112012005951A2 (ar)
IN2012DN01314A (ar)
BR112012007671A2 (ar)
BR112012009404A2 (ar)
BR122017013721A2 (ar)